A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinoma.
- Resource Type
- Article
- Source
- Cancer (0008543X); May2005, Vol. 103 Issue 10, p2035-2041, 7p
- Subject
- Language
- ISSN
- 0008543X